Hypoxia / Hypercapnia : STEM ALPHA.S3

CD34+ cells obtained from “good mobilizers” are more activated and ... 

de Z Ivanovic - 2010 - As described recently,13 CD34+ cells (50 × 103/mL) were resuspended in serum-free, cytokine-free liquid storage medium (Stem alpha S3, ... onlinelibrary.wiley.com › ... › Journal Home › Vol 50 Issue


Marija Vlaski, et al. 2009. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo . Experimental Hematology, 37, Issue 5, May 2009, 573-584.

Krstic A., et al. 2009. Low O2 concentrations enhance the positive effect of IL-17 on the mainteance of erythroid progenitors during co-culture of CD34+ and mesenchymal stem cells. European cytokine network, 20, number 1, 10-6.

Ivanovic Z., 2009. Physiological, ex vivo cell oxygenation is necessary
for a true insight into cytokine biology. Eur. Cytokine Netw., 20 n° 1, 2009, 7-9, REVIEW ARTICLE.

Ivanovic Z., 2009. Hypoxia or In Situ Normoxia: The Stem Cell Paradigm. J. Cell. Physiol. 219: 271–275, 2009.


[PDF] 2006

2006 résumés pjets financés AOR greffe

Format de fichier: PDF/Adobe Acrobat - Afficher
Stem Alpha S3 sera utilisée soit sans cytokine (2 équipes participantes), ... métylcellulose préfabriquée (Stem Alpha 1D). ; Les cellules souches ...


Ivanovic Z. et al. (2006) Transplantation and cellular engineering. Whole-blood leukodepletion filters as a source of CD34+ progenitors potentially usable in cell therapy. Transfusion, 46, 1, 118-125.


Somatic Stem Cells-STEMALPHA.Cryo3 #5617

Production of Human dental pulp cells

Production of Human dental pulp cells with a medicinal manufacturing approach, 2015. Ducret et al. Basic Research Biology. 

Osteoblastic differenciation

Osteoblastic Differentiation of Wharton Jelly Biopsy Specimens and Their Mesenchymal Stromal Cells after Serum-Free Culture, 2014. Andreas A. Mueller et al. Plast. Reconstr. Surg. 134: 59e, 2014.

Mesenchymal Stem Cells

Encapsulation of Mesenchymal Stem Cells by Bioscaffolds Protects  Cell Survival and Attenuates Neuroinflammatory Reaction  in Injured Brain Tissue After Transplantation, 2013. Anna Sarnowska et al. 
Cell Transplantation, Vol. 22, Supplement 1, pp. S67–S82, 2013

Neurogenic properties

Neurogenic Properties and a Clinical Relevance of Multipotent Stem Cells Derived from Cord Blood Samples Stored in the Biobanks, 2012. Marcin Jurga et al. STEM CELLS AND DEVELOPMENT Volume 21, Number 6, 2012.

Cryopreservation STEM ALPHA.Cryo3

A chemically defined medium for rabbit embryo cryopreservation


Pierre Bruyèrea *, Anne Baudotb, Thierry Jolya,c, Loris Commina, Pierre Guérina, Gérard Louisb, Samuel Buffa


aUniversité de Lyon, VetAgro Sup, UPSP 2011.03.101, ICE, F-69280, Marcy l’étoile


bUniversité Paris-Descartes, Sorbonne Paris Cité, F-75270, Paris


cISARA-Lyon, F-69364, Lyon


*Corresponding author. Tel: (+33) 4 78 87 26 19; Fax: (+33) 4 78 87 67 88.

 E-mail address: pierre.bruyere@vetagro-sup.fr 

Vaccine production (Influenza)

Morphological and Proliferative Characteristics of Vero and MDCK Cells during Culturing in Nutrient Media on the Basis of Hydrolysates of Plant Proteins.

N A Mazurkova, E I Ryabchikova, G P Troshkova, T N Getmanova, T P Sumkina, L N Shishkina, A N Sergeev

Federal State Institution of Science, State Research Center of Virology and Biotechnology "Vector", Russian Consumer Supervision, Novosibirsk oblast, Kol'tsovo.

Bulletin of Experimental Biology and Medicine (impact factor: 0.27). 05/2009; 147(4):551-4.


Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally

Yuri Ghendon*, Stanislav Markushin, Yuri Vasiliev, Irina Akopova, Irina Koptiaeva, Georgy Krivtsov, Olga Borisova, Nelly Ahmatova, Ekaterina Kurbatova, Svetlana Mazurina, Valentina Gervazieva

Journal of Medical Virology

Volume 81, Issue 3, pages 494–506, March 2009


Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

The use of components of plant origin in the development of production technology for live cold-adapted cultural influenza vaccine  2008


N. A. Mazurkova, T. D. Kolokol’tsova, E. A. Nechaeva, L. N. Shishkina and A. N. Sergeev

From the issue entitled "This issue is a translation of Byulleten' Eksperimental'noi Biologii i Meditsiny (Bulletin of Experimental Biology and Medicine) and Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)"



Y. Genzel, M. Fischer and U. Reichl Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture Vaccine, Volume 24, Issue 16, 12 April 2006, Pages 3261-3272

Y.Z. Ghendon, S.G. Markushin, I.I. Akopova, I.B. Koptiaeva, E.A. Nechaeva, L.A. Mazurkova, I.F. Radaeva and T.D. Kolokoltseva Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine Vaccine, Volume 23, Issue 38, 7 September 2005, Pages 4678-4684

Elena Nechaeva, Nataliya Mazurkova, Yuri Gendon, Tamara Kolokoltsova, New Technology for Producing -Live Influenza Vaccine Using a Serum-Free Medium Supplemented with Additives and Stabilizers of Plant Origin. Bioprocess international, 2004.


Andre-Garnier E, Milpied N, Boutolleau D, Saiagh S, Billaudel S and Imbert-Marcille B-M (2004). Reactivation of human herpesvirus + during ex vivo expansion of circulating CD34+ haematopoietic stem cells. J Gen Virol. 85, 3333-3336.